Mangoceuticals, Inc. MGRX US Equity☆

Mangoceuticals, Inc. (Nasdaq: MGRX), an SEC filer in Services-Misc Health & Allied Services, NEC, closed at $0.40, +0.5%, on 2026-08-28, with a market cap of $9M, a return on equity of -141.6%, a net margin of -4526.8% and 3-year sales growth of 270.9%. Institutional ownership, earnings history and filed financials are on the tabs below.